Uniphos Enterprises working capital

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

149.09×	149.09×	0.79×	1.75×	0.00×	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
159.17×	159.17×	3.66×	7.95×	143.30×
−10.08×	−10.08×	−2.87×	−6.20×	−143.30×
1.37×	1.68×	7.73×	1.10×	0.03×
0.01×	0.01×	0.05×	0.02×	0.00×
−0.16×	−0.16×	−9.76×	−0.09×	−0.04×
0.91×	0.91×	0.71×	1.12×	0.51×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

UNIENTER₹80.15

Uniphos Enterprises Limited

· Chemicals

₹ CrorePeersVINYLINDIA SRDMcap ₹557 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Receivable Days (DSO)	0.00	1.75	0.79	149.09	149.09
Payable Days (DPO)	143.30	7.95	3.66	159.17	159.17
Cash Conversion Cycle (days)	-143.30	-6.20	-2.87	-10.08	-10.08
Working Capital Turnover	0.03	1.10	7.73	1.68	1.37
Asset Turnover	0.00	0.02	0.05	0.01	0.01
Cash Conversion (CFO/Net Income)	-0.04	-0.09	-9.76	-0.16	-0.16
CFO/EBITDA	0.51	1.12	0.71	0.91	0.91

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.